| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 2.695 | 44.220 | 65.959 | 46.108 |
| Total Income - EUR | - | - | - | - | - | - | 2.695 | 44.240 | 65.959 | 46.108 |
| Total Expenses - EUR | - | - | - | - | - | - | 617 | 6.436 | 16.014 | 42.100 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 2.079 | 37.804 | 49.945 | 4.007 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.998 | 36.678 | 49.285 | 2.624 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Ellitederma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 596 | 397 | 3.635 | 242.064 |
| Current Assets | - | - | - | - | - | - | 1.508 | 38.430 | 46.739 | 20.365 |
| Inventories | - | - | - | - | - | - | 0 | 1.561 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 28.833 | 21.644 | 2.086 |
| Cash | - | - | - | - | - | - | 1.508 | 8.036 | 25.096 | 8.227 |
| Shareholders Funds | - | - | - | - | - | - | 2.038 | 36.727 | 49.349 | 40.038 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 66 | 2.100 | 1.025 | 222.392 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ellitederma S.r.l.